BACKGROUND: Although various guidelines regarding neuroendocrine tumors were released, treatment for rectal neuroendocrine tumors with size between 1 and 2 cm has not been explicitly elucidated. The determinant factor of the choice between endoscopic resection and radical surgery is whether lymph node involvement exists. AIM: This study aims to explore factors associated with lymph node involvement in rectal neuroendocrine tumors by conducting a meta-analysis. METHODS: A broad literature research of Pubmed, Embase&Medline, and The Cochrane Library was performed, and systematic review and meta-analysis about factors associated with lymph node involvement were conducted. RESULTS: Seven studies were included in this meta-analysis. Tumor size > 1 cm (odds ratio (OR) 6.72, 95% confidence interval (CI) [3.23, 14.02]), depth of invasion (OR 5.06, 95% CI [2.30, 11.10]), venous invasion (OR 5.92, 95% CI [2.21, 15.87]), and central depression (OR 3.00, 95% CI [1.07, 8.43]) were significantly associated with lymph node involvement. CONCLUSION: The available clinical evidence suggests that tumor size > 1 cm, invasion of muscularis properia, venous invasion, and central depression could be risk factors of lymph node involvement, while other factors reported by few studies need further research.
BACKGROUND: Although various guidelines regarding neuroendocrine tumors were released, treatment for rectal neuroendocrine tumors with size between 1 and 2 cm has not been explicitly elucidated. The determinant factor of the choice between endoscopic resection and radical surgery is whether lymph node involvement exists. AIM: This study aims to explore factors associated with lymph node involvement in rectal neuroendocrine tumors by conducting a meta-analysis. METHODS: A broad literature research of Pubmed, Embase&Medline, and The Cochrane Library was performed, and systematic review and meta-analysis about factors associated with lymph node involvement were conducted. RESULTS: Seven studies were included in this meta-analysis. Tumor size > 1 cm (odds ratio (OR) 6.72, 95% confidence interval (CI) [3.23, 14.02]), depth of invasion (OR 5.06, 95% CI [2.30, 11.10]), venous invasion (OR 5.92, 95% CI [2.21, 15.87]), and central depression (OR 3.00, 95% CI [1.07, 8.43]) were significantly associated with lymph node involvement. CONCLUSION: The available clinical evidence suggests that tumor size > 1 cm, invasion of muscularis properia, venous invasion, and central depression could be risk factors of lymph node involvement, while other factors reported by few studies need further research.
Authors: Sean C Glasgow; Joshua I S Bleier; Lawrence J Burgart; Charles O Finne; Ann C Lowry Journal: J Gastrointest Surg Date: 2012-01-19 Impact factor: 3.452
Authors: Lowell B Anthony; Jonathan R Strosberg; David S Klimstra; William J Maples; Thomas M O'Dorisio; Richard R P Warner; Gregory A Wiseman; Al B Benson; Rodney F Pommier Journal: Pancreas Date: 2010-08 Impact factor: 3.327
Authors: K-N Shim; S-K Yang; S-J Myung; H-S Chang; S-A Jung; J W Choe; Y J Lee; J S Byeon; J H Lee; H-Y Jung; W-S Hong; J-H Kim; Y I Min; J C Kim; J-S Kim Journal: Endoscopy Date: 2004-04 Impact factor: 10.093
Authors: Beiqun Zhao; Hannah M Hollandsworth; Nicole E Lopez; Lisa A Parry; Benjamin Abbadessa; Bard C Cosman; Sonia L Ramamoorthy; Samuel Eisenstein Journal: J Gastrointest Surg Date: 2020-02-03 Impact factor: 3.452